Suchergebnisse - "Sas, David J"

PubPharm (69)

1

Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Sas, D. | Mara, K. | Mehta, R. | +6

2

Examination of nutritional factors associated with urolithiasis risk in plant based meat alternatives marketed to children and infants

enthalten in: Journal of pediatric urology | 2023

von Ungerer, G. | Liaw, C. | Potretzke, A. | +4

3

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant

enthalten in: Kidney international reports | 2023

von Genena, K. | Sas, D. | Milliner, D. | +1

4

Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1

enthalten in: Pediatric nephrology | 2023

von Sas, D. | Mara, K. | Mehta, R. | +6

5

Patient Satisfaction Scores Impact Pediatrician Practice Patterns, Job Satisfaction, and Burnout

enthalten in: Clinical pediatrics | 2023

von Sas, D. | Absah, I. | Phelan, S. | +5

6

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1 : 12-month analysis of the phase 3 ILLUMINATE-B trial

enthalten in: Pediatric nephrology (Berlin, Germany) | 2023

von Hayes, W. | Sas, D. | Magen, D. | +9

7

An investigation of metabolic disturbances, including urinary stone disease, hypothyroidism, and osteoporosis in basal cell nevus syndrome

enthalten in: Pediatric dermatology | 2022

von Schlaht, K. | Sas, D. | Davis, D. | +1

8

Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2022

von Singh, P. | Vaughan, L. | Schulte, P. | +3

9

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial

enthalten in: Pediatric nephrology | 2022

von Hayes, W. | Sas, D. | Magen, D. | +9

10

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial

enthalten in: Pediatric nephrology | 2022

von Hayes, W. | Sas, D. | Magen, D. | +9

1
2
3
4
5
6
7
Nächster »
[7]